Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
National Partners in Healthcare Acquires Medstream Anesthesia

National Partners in Healthcare Acquires Medstream Anesthesia

National Partners in Healthcare (NPH) announced on April 12 that it has expanded into 12 states with the acquisition of Medstream Anesthesia. Medstream Anesthesia is run by more than 700 providers. McGuireWoods LLP provided legal counsel to National Partners in Healthcare. SVB Securities served as exclusive financial advisor and Hall Render Killian Heath & Lyman PC served as legal advisor to Medstream Anesthesia. Founded in 2018, NPH partners with anesthesiologists and CRNAs providing long-term sustainable solutions for their medical practices. NPH is a joint venture between Archimedes Health Investors LLC and Assured Healthcare Partners. This transaction adds more than 700 providers... Read More »
Advanced Reconstructive Surgery Alliance Acquires CimiSurgical

Advanced Reconstructive Surgery Alliance Acquires CimiSurgical

Advanced Reconstructive Surgery Alliance (ARSA) announced its acquisition of CimiSurgical on April 10, marking the 156th Physician Medical Groups transaction of the year.  CimiSurgical provides plastic and reconstructive surgery to the Maywood and Ridgewood areas of New Jersey. It is run by four providers. Based in Red Bank, New Jersey, ARSA is an alliance of more than 50 plastic and reconstructive surgeons. CimiSurgical is the second practice to join ARSA in 2023, following the January acquisition of Plastic, Reconstructive & Microsurgical Associates. With the addition of CimiSurgical, ARSA adds a premier partner in New Jersey and further expands its footprint in the northeast... Read More »
The IMA Group Acquires Accelemed Research Institute in Second Move of the Year

The IMA Group Acquires Accelemed Research Institute in Second Move of the Year

The IMA Group on April 11 announced that it entered into an agreement to acquire Accelemed Research Institute.  The acquisition expands The IMA Group’s depth in multi-therapeutic clinical trial sites focused on cardiometabolic and GI diseases such as non-alcoholic steatohepatitis, obesity, high cholesterol and diabetes. The financial terms were not disclosed.  Accelemed Research Institute operates out of Austin, Texas and conducts clinical trials to allow safety and efficacy data to be collected for new drugs, medical devices or treatment techniques. The IMA Group provides government workers with medical, psychological and related evaluations, as well as ancillary services.... Read More »
SMBC Leasing and Finance Acquires Fresenius Kidney Care East Greensboro

SMBC Leasing and Finance Acquires Fresenius Kidney Care East Greensboro

SMBC Leasing and Finance Inc. announced on April 11 that it acquired Fresenius Kidney Care East Greensboro, a medical office building (MOB) in Greensboro, North Carolina for $4.4 million The facility, which has a dialysis center, was built on 1.9 acres in 2003 and consists of 12,588 square feet of rentable space. The price was approximately $350 per square foot.  SMBC Leasing and Finance Inc., a portfolio company of SMBC Americas Holdings, Inc., is a leasing company based in New York City. Fresenius’s five other North Carolina locations will remain open. According to data captured in the LevinPro HC database, this transaction represents the 63rd MOB acquisition of the year.... Read More »
Discovery Life Sciences Acquires ReachBio Research Labs

Discovery Life Sciences Acquires ReachBio Research Labs

Discovery Life Sciences has acquired ReachBio Research Labs, a Seattle-based contract research organization (CRO). This acquisition will allow Discovery Life Sciences to scale its consolidated drug discovery and preclinical development offerings to give customers access to a broader range of specialized cell biology services. Financial terms of the deal were not disclosed. ReachBio Research Labs specializes in cell-based assays, predictive hematotoxicity and drug screening services. The company provides primary cell biology-based contract research services and products to the drug development and life science research communities. Founded in 2018, Discovery Life Sciences provides... Read More »
Spectral MD Holdings to be Listed on Nasdaq Through Business Combination with Rosecliff Acquisition Corp I SPAC

Spectral MD Holdings to be Listed on Nasdaq Through Business Combination with Rosecliff Acquisition Corp I SPAC

Spectral MD Holdings, Ltd. announced on April 11 that it has entered into an agreement to combine with Rosecliff Acquisition Corp I, a special purpose acquisition company (SPAC) listed on Nasdaq. The combined company expects to operate under the name Spectral AI and to be listed on Nasdaq under the symbol “MDAI”. The combined company will operate under the same management team, led by Spectral MD founder and CEO Wensheng Fan with current Spectral MD shareholders rolling 100% of their equity into the transaction. Net proceeds of the proposed transaction will be used to accelerate readiness for material potential federal contracts, to enhance Spectral MD’s efforts for broad... Read More »
ClareMedica Health Partners Acquires Plaza Medical Centers

ClareMedica Health Partners Acquires Plaza Medical Centers

ClareMedica Health Partners, a portfolio company of private equity firm Revelstoke Capital Partners, announced on April 11 that it purchased Plaza Medical Centers for an undisclosed price. McGuireWoods LLP acted as legal counsel to Revelstoke and ClareMedica. Oppenheimer & Co. Inc. acted as financial advisor and Holland & Knight LLP acted as legal counsel to Plaza Medical Centers.  Plaza Medical Centers is a patient-first focused primary care provider for Medicare Advantage (MA) patients.  It operates out of seven locations in Florida and is run by 17 providers. Based in Miami Lakes, Florida, ClareMedica Health Partners is a provider of value-based primary care services... Read More »
Seven Hills-Backed Reliable Medical Acquires Capstone Medical Partners

Seven Hills-Backed Reliable Medical Acquires Capstone Medical Partners

Reliable Medical Supply, a portfolio company of Chicago-based private equity firm Seven Hills Capital, announced the purchase of Washington-based Capstone Medical Partners for an undisclosed price. The acquisition further expands Reliable Medical Supply’s footprint into the Pacific Northwest, as well as enhances its solutions to long-term care facilities. Capstone Medical Partners is a Complex Rehab Technology (CRT) & Durable Medical Equipment (DME) provider based in Lakewood, Washington. Capstone Medical specializes in providing CRT & DME to long-term care facilities. Reliable Medical Supply provides CRT, clinical respiratory products, DME and supplies to serve a fragile patient... Read More »
Thurston Group Partners With Esthetics Center, Forms MedSpa Platform Alpha Aesthetics Partners

Thurston Group Partners With Esthetics Center, Forms MedSpa Platform Alpha Aesthetics Partners

Thurston Group has closed on a partnership with Esthetics Center to form Alpha Aesthetics Partners, a management services organization focused on partnering with leading medical aesthetics practices nationwide. Esthetics Center will become the anchor affiliate of Alpha Aesthetics Partners. In partnership with Thurston Group, Alpha Aesthetics Partners will execute an aggressive growth strategy focused on partnerships with high quality, like-minded groups across the country. Financial terms of the deal were not disclosed. Esthetics Center is a MedSpa group based in Sacramento, California. Led by facial plastic surgeon Dr. Reginald Rice, and with the addition of CEO John Wheeler in 2018,... Read More »
Market Pressures Take Toll on Healthcare M&A in Q1:23

Market Pressures Take Toll on Healthcare M&A in Q1:23

Headwinds have finally slowed the healthcare M&A market. Throughout 2022, deal volume soared despite challenging market conditions, but activity in the first quarter of 2023 declined by 5% compared with the fourth quarter of 2022. The year-over-year drop was much more severe, falling 18%, or 531 deals compared with 647 deals. Factors such as growing labor costs, inflation and high-interest rates have stifled deal activity. Although we’re struggling to call any quarter with 500-plus deals slow, the opening three months of 2023 fell short of the 2022 quarterly average of 603 deals.    The swing in announced spending wasn’t nearly as dramatic. In the first quarter of 2023,... Read More »